Application 125514
- Type
- BLA
- Sponsor
- MERCK SHARP DOHME
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125514 | Keytruda | pembrolizumab | 351(a) | Disc | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | KEYTRUDA | PEMBROLIZUMAB | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER | 50MG | Yes | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KEYTRUDA | PEMBROLIZUMAB | Merck Sharp & Dohme LLC | 9333c79b-d487-4538-a9f0-71b91a02b287 | 2026-07-10 | Warnings, Adverse reactions | BLA125514 0006-3026 0006-3029 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme LLC | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme LLC | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme LLC | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme LLC | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme LLC | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3026 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
| 0006-3029 | KEYTRUDA | pembrolizumab | Merck Sharp & Dohme Corp. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85931 | SUPPL | 2026-05-18 |
| 85900 | SUPPL | 2026-05-13 |
| 85653 | SUPPL | 2026-04-08 |
| 85645 | SUPPL | 2026-04-07 |
| 85009 | SUPPL | 2026-02-12 |
| 85008 | SUPPL | 2026-02-12 |
| 84292 | SUPPL | 2025-11-25 |
| 84291 | SUPPL | 2025-11-25 |
| 84272 | SUPPL | 2025-11-24 |
| 82939 | SUPPL | 2025-07-25 |
| 82916 | SUPPL | 2025-07-24 |
| 82568 | SUPPL | 2025-06-13 |
| 82563 | SUPPL | 2025-06-13 |
| 82510 | SUPPL | 2025-06-09 |
| 82484 | SUPPL | 2025-06-09 |
| 82459 | SUPPL | 2025-06-05 |
| 82464 | SUPPL | 2025-06-04 |
| 82450 | SUPPL | 2025-06-03 |
| 82310 | SUPPL | 2025-05-27 |
| 81993 | SUPPL | 2025-04-25 |
| 81976 | SUPPL | 2025-04-24 |
| 81165 | SUPPL | 2025-02-07 |
| 81010 | SUPPL | 2025-02-05 |
| 80564 | SUPPL | 2024-12-13 |
| 80558 | SUPPL | 2024-12-13 |
| 80266 | SUPPL | 2024-11-21 |
| 80263 | SUPPL | 2024-11-21 |
| 79655 | SUPPL | 2024-09-19 |
| 79650 | SUPPL | 2024-09-18 |
| 79371 | SUPPL | 2024-08-12 |
| 79348 | SUPPL | 2024-08-09 |
| 79340 | SUPPL | 2024-08-08 |
| 79270 | SUPPL | 2024-08-02 |
| 78751 | SUPPL | 2024-07-02 |
| 78811 | SUPPL | 2024-06-18 |
| 78808 | SUPPL | 2024-06-17 |
| 78777 | SUPPL | 2024-06-12 |
| 77789 | SUPPL | 2024-03-12 |
| 77778 | SUPPL | 2024-03-12 |
| 77373 | SUPPL | 2024-01-31 |
| 77317 | SUPPL | 2024-01-26 |
| 77310 | SUPPL | 2024-01-26 |
| 77218 | SUPPL | 2024-01-16 |
| 77209 | SUPPL | 2024-01-12 |
| 77051 | SUPPL | 2023-12-19 |
| 77050 | SUPPL | 2023-12-19 |
| 76865 | SUPPL | 2023-12-15 |
| 76862 | SUPPL | 2023-12-15 |
| 76765 | SUPPL | 2023-12-12 |
| 76617 | SUPPL | 2023-11-17 |
| 76583 | SUPPL | 2023-11-16 |
| 76540 | SUPPL | 2023-11-08 |
| 76030 | SUPPL | 2023-11-02 |
| 76029 | SUPPL | 2023-11-02 |
| 76021 | SUPPL | 2023-11-01 |
| 76020 | SUPPL | 2023-11-01 |
| 75920 | SUPPL | 2023-10-24 |
| 75901 | SUPPL | 2023-10-24 |
| 75832 | SUPPL | 2023-10-17 |
| 75745 | SUPPL | 2023-10-16 |
| 75727 | SUPPL | 2023-10-13 |
| 75726 | SUPPL | 2023-10-13 |
| 75087 | SUPPL | 2023-08-16 |
| 75086 | SUPPL | 2023-08-16 |
| 75070 | SUPPL | 2023-08-15 |
| 75069 | SUPPL | 2023-08-15 |
| 75021 | SUPPL | 2023-08-09 |
| 74651 | SUPPL | 2023-06-29 |
| 74650 | SUPPL | 2023-06-29 |
| 73959 | SUPPL | 2023-04-06 |
| 73945 | SUPPL | 2023-04-04 |
| 73942 | SUPPL | 2023-04-03 |
| 73904 | SUPPL | 2023-03-29 |
| 73902 | SUPPL | 2023-03-29 |
| 73302 | SUPPL | 2023-01-27 |
| 73300 | SUPPL | 2023-01-26 |
| 73299 | SUPPL | 2023-01-26 |
| 73291 | SUPPL | 2023-01-25 |
| 73286 | SUPPL | 2023-01-25 |
| 72930 | SUPPL | 2022-12-20 |
| 72920 | SUPPL | 2022-12-19 |
| 71747 | SUPPL | 2022-08-08 |
| 71743 | SUPPL | 2022-08-08 |
| 71470 | SUPPL | 2022-06-28 |
| 71447 | SUPPL | 2022-06-24 |
| 71422 | SUPPL | 2022-06-22 |
| 71134 | SUPPL | 2022-05-23 |
| 71133 | SUPPL | 2022-05-23 |
| 71127 | SUPPL | 2022-05-23 |
| 70619 | SUPPL | 2022-03-28 |
| 70579 | SUPPL | 2022-03-22 |
| 70576 | SUPPL | 2022-03-21 |
| 70117 | SUPPL | 2022-02-08 |
| 70116 | SUPPL | 2022-02-08 |
| 70108 | SUPPL | 2022-02-08 |
| 69714 | SUPPL | 2021-12-21 |
| 69625 | SUPPL | 2021-12-17 |
| 69624 | SUPPL | 2021-12-17 |
| 69497 | SUPPL | 2021-12-07 |
| 69475 | SUPPL | 2021-12-03 |